Literature DB >> 16730429

The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.

Mark van der Gaag1, Tonko Hoffman, Mila Remijsen, Ron Hijman, Lieuwe de Haan, Berno van Meijel, Peter N van Harten, Lucia Valmaggia, Marc de Hert, Anke Cuijpers, Durk Wiersma.   

Abstract

OBJECTIVE: The lack of fit of 25 previously published five-factor models for the PANSS items, can be due to the statistics used. The purpose of this study was to use a 'new' statistical method to develop and confirm an improved five-factor model. The improved model is both complex and stable. Complex means that symptoms can have multiple factor loadings, because they have multiple causes, not because they are ill defined. Stable means that the complex structure is found repeatedly in validations.
METHODS: A ten-fold cross-validation (10 CV) was applied on a large data set (N = 5769) to achieve an improved factor model for the PANSS items. The advantages of 10 CV are minimal effect of sample characteristics and the ability to investigate the stability of items loading on multiple factors.
RESULTS: The results show that twenty-five items contributed to the same factor all ten validations with one item showing a consistent loading on two factors. Three items were contributing to the same factor nine out of ten validations, and two items were contributing to the same factor six to eight times. The resulting five-factor model covers all thirty items of the PANSS, subdivided in the factors: positive symptoms, negative symptoms, disorganization, excitement, and emotional distress. The five-factor model has a satisfactory goodness-of-fit (Comparative Fit Index = .905; Root Mean Square Error of Approximation = .052).
CONCLUSIONS: The five-factor model developed in this study is an improvement above previously published models as it represents a complex factor model and is more stable.

Mesh:

Year:  2006        PMID: 16730429     DOI: 10.1016/j.schres.2006.03.021

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  117 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

Review 2.  Brexpiprazole: so far so good.

Authors:  Saibal Das; Preeti Barnwal; Blessed Winston A; Somnath Mondal; Indranil Saha
Journal:  Ther Adv Psychopharmacol       Date:  2016-02

3.  Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.

Authors:  Todd S Woodward; Kwanghee Jung; Geoffrey N Smith; Heungsun Hwang; Alasdair M Barr; Ric M Procyshyn; Sean W Flynn; Mark van der Gaag; William G Honer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-15       Impact factor: 5.270

4.  Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia.

Authors:  Jochen Kindler; Kay Jann; Philipp Homan; Martinus Hauf; Sebastian Walther; Werner Strik; Thomas Dierks; Daniela Hubl
Journal:  Schizophr Bull       Date:  2013-12-10       Impact factor: 9.306

5.  Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events.

Authors:  Lindy-Lou Boyette; Daniëlla van Dam; Carin Meijer; Eva Velthorst; Wiepke Cahn; Lieuwe de Haan; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2014-04-25       Impact factor: 9.306

6.  The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.

Authors:  Jose A Cortes-Briones; John D Cahill; Patrick D Skosnik; Daniel H Mathalon; Ashley Williams; R Andrew Sewell; Brian J Roach; Judith M Ford; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2015-03-30       Impact factor: 13.382

7.  The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2016-08-09       Impact factor: 3.222

8.  Self-face recognition in schizophrenia is related to insight.

Authors:  C Heinisch; S Wiens; M Gründl; G Juckel; M Brüne
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-14       Impact factor: 5.270

9.  Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study.

Authors:  Patrick Domen; Sanne Peeters; Stijn Michielse; Ed Gronenschild; Wolfgang Viechtbauer; Alard Roebroeck; Jim van Os; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

10.  Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Authors:  J L McClay; D E Adkins; K Aberg; S Stroup; D O Perkins; V I Vladimirov; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2009-09-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.